U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07387211) titled 'Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region' on Jan. 28.
Brief Summary: The aim of the study is to find the proportion of people in the population of the Olomouc Region with the presence of IgG (or IgM) antibodies against the S and N antigens of the SARS-CoV-2 virus, therefore people who have already encountered the SARS-CoV-2 virus with manifest antibody formation, or people who have undergone vaccination against COVID-19.
Study Start Date: Jan. 18, 2022
Study Type: INTERVENTIONAL
Condition:
SARS-CoV-2
SARS-CoV-2 (COVID-19) Infection
Intervention:
PROCEDURE: Blood sampling
Venous blood sampling three times on th...